comparemela.com

Latest Breaking News On - Patrik dahlen - Page 4 : comparemela.com

Immunovia AB: Invitation to Presentation of Immunovia's Interim Report January

LUND, Sweden, Oct. 29, 2021 /PRNewswire/ Immunovia will publish the company's interim report for the period January 1 - September 30, 2021 on Thursday, November 11, 2021 at 16:00 CET. Investors

United statesUnited kingdomPrnewswire immunoviaImmray pancan dPatrik dahlenImmunovia incDepartment of immuntechnology at lund universityHealth cancer centerLund universityCancer center

Invitation to Presentation of Immunovia's Interim Report January

/PRNewswire/ Immunovia will publish the company s interim report for the period January 1 - September 30, 2021 on Thursday, November 11, 2021 at 16:00 CET..

United statesUnited kingdomPrnewswire immunoviaPatrik dahlenImmunovia incDepartment of immuntechnology at lund universityHealth cancer centerLund universityCancer centerImmunovia ab

Immunovia, Inc.'s Medical Director Dr. Thomas King Invited as Keynote Speaker by US National Cancer Institute

/PRNewswire/ Immunovia AB (publ) ("Immunovia"), a diagnostic company that develops and sells highly accurate blood tests for the early detection of cancer,.

United statesImmunovia immrayPatrik dahlenThomas kingPancreatic cancer detection consortiumUs national cancer instituteImmunovia incSteering committee meetingDepartment of immuntechnology at lund universityHealth cancer centerMedical directorCancer institutePrincipal investigatorsLund universityCancer centerImmunovia ab

Immunovia, Inc.'s Medical Director Dr. Thomas King Invited as Keynote Speaker by US National Cancer Institute

/PRNewswire/ Immunovia AB (publ) ("Immunovia"), a diagnostic company that develops and sells highly accurate blood tests for the early detection of cancer,.

United statesImmunovia immrayPatrik dahlenThomas kingPancreatic cancer detection consortiumUs national cancer instituteImmunovia incSteering committee meetingDepartment of immuntechnology at lund universityHealth cancer centerMedical directorCancer institutePrincipal investigatorsLund universityCancer centerImmunovia ab

Immunovia AB: Immunovia, Inc.'s Medical Director Dr. Thomas King Invited as Keynote Speaker by US National Cancer Institute

LUND, Sweden, Oct. 29, 2021 /PRNewswire/ Immunovia AB (publ) ("Immunovia"), a diagnostic company that develops and sells highly accurate blood tests for the early detection of cancer, today

United statesImmunovia immray pancan dImmray pancan dPatrik dahlenThomas kingPancreatic cancer detection consortiumUs national cancer instituteImmunovia incSteering committee meetingDepartment of immuntechnology at lund universityHealth cancer centerMedical directorCancer institutePrincipal investigatorsLund universityCancer center

vimarsana © 2020. All Rights Reserved.